Adam Gibb

Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.

Neil Bodsworth, R. J. Crooks, Sueli Donizete Borelli et al. · Sexually Transmitted Infections · 1997 · 94 citations · Full text

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

Adam Gibb, C. Jones, Adrian Bloor et al. · Haematologica · 2012 · 94 citations · Full text

Relapsed/refractory Hodgkin Lymphoma, Transplantation Medicine, Immunology +21

Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.

R Patel, Neil Bodsworth, P D Woolley et al. · Sexually Transmitted Infections · 1997 · 93 citations · Full text

BLOCKADE OF THE PD‐1 CHECKPOINT WITH ANTI–PD‐L1 ANTIBODY AVELUMAB IS SUFFICIENT FOR CLINICAL ACTIVITY IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (CHL)

R. Chen, Adam Gibb, Graham P. Collins et al. · Hematological Oncology · 2017 · 35 citations · Full text

Immunodeficiencies, Immunology, Immune Regulation +18

Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Tim Illidge, Réda Bouabdallah, Robert Chen et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 34 citations

Lymphoid Neoplasia, Allogeneic Transplant, Transplantation +15